AdaptHealth Corp. (NASDAQ:AHCO) Given Average Rating of “Hold” by Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have been given an average recommendation of “Hold” by the seven brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $12.10.

A number of brokerages have issued reports on AHCO. Jefferies Financial Group downgraded shares of AdaptHealth from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $14.50 to $8.00 in a research note on Monday, January 8th. Truist Financial increased their price target on shares of AdaptHealth from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Royal Bank of Canada restated an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a research report on Monday, March 4th. Finally, UBS Group raised their target price on AdaptHealth from $9.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, February 28th.

AdaptHealth Trading Up 4.0 %

Shares of NASDAQ:AHCO opened at $9.96 on Monday. The business’s 50 day simple moving average is $10.05 and its 200 day simple moving average is $8.44. AdaptHealth has a 1 year low of $6.37 and a 1 year high of $15.37. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.21 and a quick ratio of 1.00. The company has a market capitalization of $1.32 billion, a P/E ratio of -1.88, a P/E/G ratio of 0.65 and a beta of 1.02.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, February 27th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.20 by $0.44. AdaptHealth had a positive return on equity of 8.84% and a negative net margin of 21.21%. The firm had revenue of $858.23 million during the quarter, compared to the consensus estimate of $825.94 million. On average, research analysts anticipate that AdaptHealth will post 0.88 EPS for the current fiscal year.

Insider Activity at AdaptHealth

In other AdaptHealth news, major shareholder James E. Flynn sold 182,607 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the sale, the insider now owns 11,643,769 shares of the company’s stock, valued at $128,314,334.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other AdaptHealth news, major shareholder James E. Flynn sold 182,607 shares of the company’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $11.02, for a total value of $2,012,329.14. Following the completion of the transaction, the insider now owns 11,643,769 shares of the company’s stock, valued at approximately $128,314,334.38. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder James E. Flynn sold 52,487 shares of AdaptHealth stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $10.93, for a total value of $573,682.91. Following the sale, the insider now directly owns 11,826,376 shares in the company, valued at $129,262,289.68. The disclosure for this sale can be found here. 13.60% of the stock is owned by insiders.

Institutional Investors Weigh In On AdaptHealth

A number of institutional investors have recently added to or reduced their stakes in AHCO. PNC Financial Services Group Inc. raised its stake in shares of AdaptHealth by 6.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 24,504 shares of the company’s stock valued at $179,000 after acquiring an additional 1,382 shares during the last quarter. SummerHaven Investment Management LLC raised its position in AdaptHealth by 2.6% during the 4th quarter. SummerHaven Investment Management LLC now owns 54,754 shares of the company’s stock worth $399,000 after purchasing an additional 1,411 shares during the last quarter. Texas Permanent School Fund Corp lifted its holdings in AdaptHealth by 2.3% during the 3rd quarter. Texas Permanent School Fund Corp now owns 68,860 shares of the company’s stock worth $627,000 after buying an additional 1,551 shares during the period. GAMMA Investing LLC grew its position in shares of AdaptHealth by 197.1% in the 1st quarter. GAMMA Investing LLC now owns 2,537 shares of the company’s stock valued at $29,000 after buying an additional 1,683 shares during the last quarter. Finally, Mackenzie Financial Corp grew its position in shares of AdaptHealth by 11.1% in the 4th quarter. Mackenzie Financial Corp now owns 23,760 shares of the company’s stock valued at $173,000 after buying an additional 2,376 shares during the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.